Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

By E. Calle, Carmen Rodríguez, Kimberly A. Walker-Thurmond, M. Thun. New England Journal of Medicine, 2003

7,460 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/05f13ed6e3c90c9c28b4086ced4755bdff28a727

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Oncology

Citations in the corpus

Pharmacological management of obesity: an endocrine Society clinical practice guideline. (2015, background): “obese are at increased risk for many malignancies (7).”
Epidemiology and risk factors of urothelial bladder cancer. (2013, background): “Similar to the uncertain influence of diet on UBC incidence, no impact of body mass index as a surrogate parameter of diet on outcome in UBC patients has been reported to date [41].”
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. (2008, background): “[1] Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ.”
Author's Personal Copy Understanding the relationship between obesity and positive and negative affect: The role of psychosocial mechanisms § (2007, background): “The physical health consequences of obesity have been documented extensively, with most studies showing that the risks of chronic illness and mortality increase as one’s body mass index (BMI) increases ( Calle, Rodriguez, Walker-Thurmond, & Thun, 2003; Patterson, Frank, Kristal, & White, 2004; Yan ”
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. (2009, background): “Obesity is associated with type 2 diabetes and is itself a risk factor for breast cancer(9) and possibly for poorer breast cancer outcomes.(10,11) The common factor linking diabetes, obesity, and metabolic syndrome to cancer may be the insulin resistance and consequent hyperinsulinemia associated wi”
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma (2011, background): “Obesity has been identified as an important risk factor for HCC”
Metabolic reprogramming and cancer progression (2020, background): “Many epidemiological studies report associations between obesity and cancer, and a large prospective analysis of more than 900,000 Americans found greater than a 50% increase in cancer mortality in patients with the highest body mass index (15, 16).”
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression (2010, background): “62-fold increases in the relative risk of cancer-related death (Calle et al., 2003).”